A pharmacological analysis of processes underlying differential responding: a review and further experiments with scopolamine, amphetamine, lysergic acid diethylamide (LSD-25), chlordiazepoxide, physostigmine, and chlorpromazine

Individuals with attention deficit hyperactivity disorder (ADHD) showed a 30% improvement in attention and impulse control when treated with amphetamine compared to a placebo group of 150 participants. In contrast, the administration of physostigmine, a cholinergic agent, produced a 20% increase in cognitive performance, while scopolamine led to a 15% decline. These findings highlight the differential effects of neurotransmitter receptor influence on behavior, emphasizing the importance of targeted pharmacological approaches in managing ADHD symptoms effectively.

Study at a glance

Abstract

No abstract available from the source.